Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) has been reveling in an uncanny bull run over the last ten days. EMHTF’s chart will tell the tale, but last week the stock shot up 29% and EMHTF is continuing the charge. But this is even short-sighted when you consider a couple months ago, EMHTF was trading a little above a buck-fifty. Now, the stock is over $7.60 and drawing interest from all corners of the market. However, there are some signs that this stock faces resistance around $7.79 mark and if it falls or there is a down news cycle it could go toward the $3-5 area rapidly.
But, even some minor hiccups in price don’t dispute the fact that EMHTF is going to be a player in this huge industry. In regard to operations, EMHTF looks solid with a focus on CBD Oil coming this year. The company is developing a 1.1 million square facility in Delta British Columbia, as it looks to take its marijuana production capacity to 75,000 a year. The first phase of the project should be ready by the end of the first quarter with an additional 500,000 ft. expected to be in operation by the end of the year. EMHTF plans to trim its production capacity by next year which would put it on top of the production ladder, at a potential 300,000 kg annually.
Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) trumpets itself as a licensed producer of medical marijuana under the Access to Cannabis for Medical Purposes Regulations, which allows the company to produce and sell medical marijuana and cannabis oils to clients and other licensed producers.
Individuals may become clients of the company by registering with the company through its secure online portal or via telephone after the individual has received a medical document signed by a licensed health care practitioner setting out the daily quantity of dried marijuana, in grams, that the practitioner authorized for the person.
According to company materials, “Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) operates through Emerald Health Botanicals Inc., a wholly owned subsidiary and Licensed Producer under the Access to Cannabis for Medical Purposes Regulations. Botanicals is authorized to produce and sell both dried medical cannabis flower and medical cannabis oil in Canada. Botanicals currently operates an indoor facility in Victoria, BC, and is progressing on expansion plans for a 32-acre property in Metro Vancouver and a partnership with Village Farms, called Pure Sunfarms, utilizing a 25-acre existing greenhouse complex in Delta, BC. Botanicals is one of Canada’s most medically focused licensed producers, with a team highly experienced in life sciences product development and large-scale agribusiness. Its vision is to be a leading provider of cannabis products through its production capabilities, proprietary genetics, value-added products and branding, and superb customer experience. Emerald Health Therapeutics is associated with the Emerald Health group, which comprises multiple companies advancing diverse botanical, nutraceutical and pharmaceutical products that may provide wellness and medical benefits by interacting with the body’s endocannabinoid system.”
Find out when $EMHTF reaches critical levels. Subscribe to FinanceRegistrar.com Right Now by entering your Email in the box below.
Furthermore, in January EMHTF completed a prospectus sale to a Canadian institutional investor. Under the deal, the company issued 3 million units at a price of $5, for gross proceeds of $15 million.
The capital raise provides the much-needed firepower needed to accelerate production of medical marijuana products. Also, it should allow the company to finance research and development projects needed to accelerate the next phase of growth.
Earning a current market cap value of $500.74M, EMHTF is working its way up in a $22 billion dollar industry. The company made strong moves in 2017 to get themselves ready for legalization and the leadership team seems ready for more milestones this year. We will be writing updates as they come for this stock. Sign-up for continuing coverage on shares of $EMHTF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $EMHTF, either long or short, and we have not been compensated for this article.